We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ROSN:RUSRosneft Analysis

Data as of 2026-05-25 - not real-time

$0.02

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Rosinbomb (ROSN) is trading at $0.0198, sitting below its 20‑day (≈$0.0213) and 50‑day (≈$0.0220) simple moving averages but above the 200‑day SMA (≈$0.0170), indicating a short‑term pull‑back within a longer‑term uptrend. The 14‑day RSI of 44.6 suggests the stock is neither overbought nor oversold, while the MACD histogram remains negative, signaling bearish momentum. Volume is increasing and the 30‑day volatility is extremely high at >117%, reflecting a very active but unstable price environment. Despite a low beta of 0.36, the market’s “Extreme Greed” sentiment (fear‑greed index 91.8) may be inflating demand for this speculative micro‑cap. Fundamentally, ROSN reports zero revenue, negative trailing EPS, and no cash or debt balances, with a market cap of roughly $9 million and a historic max drawdown of 50%.
Given the lack of earnings, thin liquidity, and high price swings, the stock is best viewed as a high‑risk speculative play. The technical picture is neutral to slightly bearish, and without a clear catalyst or revenue trajectory, investors should approach ROSN cautiously, treating any exposure as a short‑term tactical position rather than a core holding.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram
  • Neutral RSI around 45
  • Increasing volume amid high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • No revenue or earnings generation
  • Extreme market greed environment
  • Low beta but very high price volatility

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental data absent (zero revenue, negative EPS)
  • Small market cap and thin liquidity
  • Potential upside only if the company launches revenue‑producing products

Key Metrics & Analysis

Financial Health

Industry P/E29.7

Technical Analysis

TrendNeutral
RSI44.6
Support$0.01
Resistance$0.02
MA 20$0.02
MA 50$0.02
MA 200$0.02
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8

Valuation

GradeFair
TypeValue

Risk Assessment

Beta0.36
Volatility117.83%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.